Chu, W-Y, Annink, K V, Nijstad, A L, Maiwald, C A, Schroth, M, Bakkali, L E, van Bel, F, Benders, M J N L, van Weissenbruch, M M, Hagen, A, Franz, A R, Dorlo, T P C, Allegaert, K, Huitema, A D R, the ALBINO Study Group, Rüdiger, M, Poets, C F, Naulaers, G, Bassler, D, Klebermass-Schrehof, K, Vento, M, Guimaraes, H, Stiris, T, Mauro, I, Metsäranta, M, Vanhatalo, S, Mazela, J & Jacobs, Y 2021, ' Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic-Ischemic Encephalopathy Neonates ', Clinical Pharmacokinetics . https://doi.org/10.1007/s40262-021-01068-0 Clinical Pharmacokinetics, 61(2):61, 321-333. Adis Clinical Pharmacokinetics. Adis International Ltd